Volume | 126,457 |
|
|||||
News | (3) | ||||||
Day High | 0.305 | Low High |
|||||
Day Low | 0.292301 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
iBio Inc | IBIO | AMEX | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.305 | 0.292301 | 0.305 | 0.294 | 0.2977 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
458 | 126,457 | $ 0.2973831 | $ 37,606 | - | 0.14 - 3.66 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
16:41:16 | formt | 156 | $ 0.2938 | USD |
iBio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.94M | 16.80M | - | 2.38M | -50.39M | -3.00 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
iBio News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical IBIO Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.3277 | 0.3428 | 0.2916 | 0.3165907 | 518,497 | -0.0339 | -10.34% |
1 Month | 0.3104 | 0.4284 | 0.262 | 0.3202815 | 656,302 | -0.0166 | -5.35% |
3 Months | 0.6231 | 0.7994 | 0.262 | 0.452993 | 640,463 | -0.3293 | -52.85% |
6 Months | 2.14 | 2.49 | 0.262 | 0.7823351 | 606,188 | -1.85 | -86.27% |
1 Year | 0.315 | 3.66 | 0.14 | 1.13 | 1,367,750 | -0.0212 | -6.73% |
3 Years | 2.07 | 3.66 | 0.14 | 1.36 | 4,478,019 | -1.78 | -85.81% |
5 Years | 0.88 | 7.85 | 0.05 | 1.86 | 6,656,064 | -0.5862 | -66.61% |
iBio Description
iBio Inc is a part of the healthcare sector. Its main business is commercialized technologies and product candidates and manufacturing services to clients and collaborators. Its main area of business is plant-based protein expression technologies for vaccines and therapeutic proteins and developing and commercializing select biopharmaceutical product candidates. Its products are used to combat various areas such as fibrotic diseases, cancers, and infectious diseases. The company operates in two segments: biologics development and licensing activities, conducted within iBio, Inc. |